JP2002512243A5 - - Google Patents

Download PDF

Info

Publication number
JP2002512243A5
JP2002512243A5 JP2000544665A JP2000544665A JP2002512243A5 JP 2002512243 A5 JP2002512243 A5 JP 2002512243A5 JP 2000544665 A JP2000544665 A JP 2000544665A JP 2000544665 A JP2000544665 A JP 2000544665A JP 2002512243 A5 JP2002512243 A5 JP 2002512243A5
Authority
JP
Japan
Prior art keywords
group
alkyl
general formula
substituted
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000544665A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002512243A (ja
JP4590097B2 (ja
Filing date
Publication date
Priority claimed from DE19817264A external-priority patent/DE19817264A1/de
Application filed filed Critical
Publication of JP2002512243A publication Critical patent/JP2002512243A/ja
Publication of JP2002512243A5 publication Critical patent/JP2002512243A5/ja
Application granted granted Critical
Publication of JP4590097B2 publication Critical patent/JP4590097B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2000544665A 1998-04-18 1999-04-07 ジヒドロピリミジン類 Expired - Lifetime JP4590097B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19817264.8 1998-04-18
DE19817264A DE19817264A1 (de) 1998-04-18 1998-04-18 Neue Dihydropyrimidine
PCT/EP1999/002344 WO1999054326A1 (de) 1998-04-18 1999-04-07 Dihydropyrimidine

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010165860A Division JP5237332B2 (ja) 1998-04-18 2010-07-23 ジヒドロピリミジン類

Publications (3)

Publication Number Publication Date
JP2002512243A JP2002512243A (ja) 2002-04-23
JP2002512243A5 true JP2002512243A5 (enExample) 2006-06-01
JP4590097B2 JP4590097B2 (ja) 2010-12-01

Family

ID=7864972

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000544665A Expired - Lifetime JP4590097B2 (ja) 1998-04-18 1999-04-07 ジヒドロピリミジン類
JP2010165860A Expired - Lifetime JP5237332B2 (ja) 1998-04-18 2010-07-23 ジヒドロピリミジン類

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010165860A Expired - Lifetime JP5237332B2 (ja) 1998-04-18 2010-07-23 ジヒドロピリミジン類

Country Status (36)

Country Link
US (3) US6696451B1 (enExample)
EP (1) EP1080086B1 (enExample)
JP (2) JP4590097B2 (enExample)
KR (1) KR100636771B1 (enExample)
CN (1) CN1159311C (enExample)
AR (1) AR018187A1 (enExample)
AT (1) ATE223401T1 (enExample)
AU (1) AU740318B2 (enExample)
BG (1) BG64649B1 (enExample)
BR (2) BR9909730B1 (enExample)
CA (1) CA2328780C (enExample)
CO (1) CO5021127A1 (enExample)
CU (1) CU23049A3 (enExample)
CZ (1) CZ293482B6 (enExample)
DE (2) DE19817264A1 (enExample)
DK (1) DK1080086T3 (enExample)
ES (1) ES2183548T3 (enExample)
GT (1) GT199900056A (enExample)
HU (1) HUP0102372A3 (enExample)
ID (1) ID27263A (enExample)
IL (2) IL138584A0 (enExample)
MY (1) MY126527A (enExample)
NO (2) NO321985B1 (enExample)
NZ (1) NZ507569A (enExample)
PE (1) PE20000427A1 (enExample)
PL (1) PL193898B1 (enExample)
PT (1) PT1080086E (enExample)
RU (1) RU2245881C9 (enExample)
SI (1) SI1080086T1 (enExample)
SK (1) SK286407B6 (enExample)
SV (1) SV1999000047A (enExample)
TR (1) TR200003011T2 (enExample)
TW (1) TW548274B (enExample)
UA (1) UA63998C2 (enExample)
WO (1) WO1999054326A1 (enExample)
ZA (1) ZA200005136B (enExample)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000058302A1 (de) * 1999-03-25 2000-10-05 Bayer Aktiengesellschaft Dihydropyrimidine und ihre verwendung zur behandlung von hepatitis b
EP1193259A4 (en) 1999-06-23 2003-01-29 Ajinomoto Kk dihydropyrimidine
WO2001045712A1 (de) * 1999-12-22 2001-06-28 Bayer Aktiengesellschaft Arzneimittelkombinationen gegen virale erkrankungen
DE10012823A1 (de) 2000-03-16 2001-09-20 Bayer Ag Arzneimittel gegen virale Erkrankungen
DE10013125A1 (de) * 2000-03-17 2001-09-20 Bayer Ag Arzneimittel gegen virale Erkrankungen
DE10013126A1 (de) * 2000-03-17 2001-09-20 Bayer Ag Arzneimittel gegen virale Erkrankungen
DE10125131A1 (de) 2001-05-23 2002-12-05 Bayer Ag Verfahren zur Spaltung des Methyl 4-(2-chlor-4-fluorphenyl)-2-(3,5-difluor-2-pyridinyl)-6-methyl-1,4-dihydro-5-pyrmidincarboxylat-Racemats
US20040092735A1 (en) * 2002-11-08 2004-05-13 Orchid Chemicals & Pharmaceuticals Limited Process for the preparation of cefuroxime sodium
CN101104617B (zh) 2006-07-10 2010-06-23 北京摩力克科技有限公司 二氢嘧啶类化合物及其用于制备治疗和预防病毒性疾病的药物的用途
CN101104604B (zh) * 2006-07-10 2011-03-02 北京摩力克科技有限公司 光学纯二氢嘧啶类化合物及其用于制备治疗和预防病毒性疾病的药物的用途
RU2452733C2 (ru) * 2007-04-27 2012-06-10 Пэдью Фарма Л.П. Антагонисты trpv1 и их применение
USRE45004E1 (en) * 2007-06-18 2014-07-08 Sunshine Lake Pharma Co., Ltd. Bromo-phenyl substituted thiazolyl dihydropyrimidines
AR067630A1 (es) 2007-07-12 2009-10-21 Novartis Ag Soluciones farmaceuticas de telbivudina y metodo de tratamiento
US20130267517A1 (en) 2012-03-31 2013-10-10 Hoffmann-La Roche Inc. Novel 4-methyl-dihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
PL2888241T3 (pl) 2012-08-24 2017-12-29 Sunshine Lake Pharma Co., Ltd. 2,4,5,6-Podstawione pochodne 3,6-dihydropirymidyny jako inhibitory polimerazy wirusa zapalenia wątroby typu B (HBV) do leczenia np. przewlekłego zapalenia wątroby
JP6113285B2 (ja) 2012-09-10 2017-04-12 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft B型肝炎ウイルス感染症の治療及び予防用の6−アミノ酸ヘテロアリールジヒドロピリミジン
CN103664899B (zh) * 2012-09-11 2017-06-16 广东东阳光药业有限公司 杂芳基取代的二氢嘧啶类化合物及其在药物中的应用
EP2917184A4 (en) * 2012-11-09 2016-06-29 Univ Indiana Res & Tech Corp ALTERNATIVE USES FOR HBV ARRANGEMENT EFFECTORS
TW201609652A (zh) * 2013-11-12 2016-03-16 陶氏農業科學公司 用於氟化化合物之過程(三)
JP6524081B2 (ja) 2013-11-19 2019-06-05 サンシャイン・レイク・ファーマ・カンパニー・リミテッドSunshine Lake Pharma Co.,Ltd. ジヒドロピリミジン化合物及び医薬におけるその適用
ES2688600T3 (es) 2013-11-27 2018-11-05 Sunshine Lake Pharma Co., Ltd. Procesos para preparar derivados de dihidropirimidina e intermedios de los mismos
MY196243A (en) 2014-03-28 2023-03-24 Sunshine Lake Pharma Co Ltd Dihydropyrimidine Compounds and Their Application In Pharmaceuticals
NZ727601A (en) 2014-05-30 2022-01-28 Qilu Pharmaceutical Co Ltd Dihydropyrimido fused ring derivative as hbv inhibitor
CN105153164B (zh) * 2014-05-30 2018-10-30 齐鲁制药有限公司 作为hbv抑制剂的二氢嘧啶并环衍生物
AU2016214799A1 (en) 2015-02-07 2017-06-15 Sunshine Lake Pharma Co., Ltd. Complexes and salts of dihydropyrimidine derivatives and their application in pharmaceuticals
WO2019001420A1 (en) * 2017-06-27 2019-01-03 Janssen Pharmaceutica Nv HETEROARYLDIHYDROPYRIMIDINE DERIVATIVES AND METHODS OF TREATING INFECTIONS WITH HEPATITIS B VIRUS
US10759774B2 (en) 2017-09-28 2020-09-01 The Curators Of The University Of Missouri Inhibitors of hepatitis B virus targeting capsid assembly
GEP20227373B (en) 2017-11-02 2022-04-25 Aicuris Gmbh & Co Kg Novel, highly active amino-thiazole substituted indole-2-carboxamides active against the hepatitis b virus (hbv)
CN111527087A (zh) 2017-11-02 2020-08-11 艾库里斯有限及两合公司 具有抗乙型肝炎病毒(hbv)活性的新的高活性的吡唑并-哌啶取代的吲哚-2-甲酰胺
EP3790866A4 (en) * 2018-05-08 2022-03-02 Janssen Sciences Ireland Unlimited Company DIHYDROPYRIMIDINE DERIVATIVES AND THEIR USES IN THE TREATMENT OF HEPATITIS B VIRUS INFECTION OR HEPATITIS B VIRUS INDUCED DISEASES
US11053235B2 (en) 2018-08-09 2021-07-06 Janssen Sciences Ireland Unlimited Company Substituted 1,4-dihydropyrimidines for the treatment of HBV infection or HBV-induced diseases
UY38437A (es) 2018-11-02 2020-05-29 Aicuris Gmbh & Co Kg Nuevas urea 6,7-dihidro-4h-pirazolo[1,5-a]pirazinas activas contra el virus de la hepatitis b (hbv)
UY38435A (es) 2018-11-02 2020-05-29 Aicuris Gmbh & Co Kg Nuevas urea 6,7-dihidro-4h-pirazol[1,5-a] pirazinas activas contra el virus de la hepatitis b (vhb)
AR116946A1 (es) 2018-11-02 2021-06-30 Aicuris Gmbh & Co Kg Derivados de urea 6,7-dihidro-4h-pirazolo[4,3-c]piridinas activas contra el virus de la hepatitis b (vhb)
CA3118339A1 (en) * 2018-11-02 2020-05-07 Aicuris Gmbh & Co. Kg Novel urea 6,7-dihydro-4h-thiazolo[5,4-c]pyridines active against the hepatitis b virus (hbv)
UY38434A (es) 2018-11-02 2020-05-29 Aicuris Gmbh & Co Kg Nuevas 6,7-dihidro-4h-pirazolo[1,5-a]pirazin indol-2-carboxamidas activas contra el virus de la hepatitis b (hbv)
PY1991603A (es) 2018-11-02 2020-09-17 Aicuris Gmbh & Co Kg Nueva 6,7-dihidro-4h-pirazolo [1,5-a] pirazina indole -2-carboxamidas activas contra el virus de la hepatitis b (vhb)
KR20210106421A (ko) 2018-12-20 2021-08-30 얀센 파마슈티카 엔.브이. 헤테로아릴디히드로피리미딘 유도체 및 b형 간염 감염의 치료 방법
EP3962914A1 (en) 2019-04-30 2022-03-09 AiCuris GmbH & Co. KG Novel indole-2-carboxamides active against the hepatitis b virus (hbv)
JP2022533007A (ja) 2019-04-30 2022-07-21 アイクリス ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト B型肝炎ウイルス(hbv)に対し活性な新規のインドリジン-2-カルボキサミド
BR112021021652A2 (pt) 2019-04-30 2021-12-21 Aicuris Gmbh & Co Kg Oxalil piperazinas inovadoras ativas contra o vírus da hepatite b (hbv)
BR112021021580A2 (pt) 2019-04-30 2022-01-04 Aicuris Gmbh & Co Kg Fenil e piridil ureias inovadoras ativas contra o vírus da hepatite b (hbv)
WO2020255016A1 (en) 2019-06-18 2020-12-24 Janssen Sciences Ireland Unlimited Company Combination of hepatitis b virus (hbv) vaccines and dihydropyrimidine derivatives as capsid assembly modulators

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL130304C (enExample) * 1964-02-12
CH550189A (de) 1971-01-08 1974-06-14 Ciba Geigy Ag Verfahren zur herstellung von neuen dibenzo (b,f) thiepincarbonsaeuren.
CH569043A5 (enExample) 1973-01-23 1975-11-14 Ciba Geigy Ag
US4371537A (en) * 1981-08-13 1983-02-01 The Dow Chemical Company Sulfur-substituted phenoxypyridines having antiviral activity
DE3234684A1 (de) * 1982-09-18 1984-03-22 Bayer Ag, 5090 Leverkusen Neue dihydropyrimidine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
JPS60185764A (ja) 1984-03-05 1985-09-21 Wako Pure Chem Ind Ltd ピリジン誘導体の新規な製造法
US4698340A (en) 1984-07-19 1987-10-06 Fujisawa Pharmaceutical Co., Ltd. Pyrimidine derivatives, processes for preparation thereof and composition containing the same
US4727073A (en) 1984-10-01 1988-02-23 Fujisawa Pharmaceutical Co., Ltd. Pyrimidine derivatives and composition of the same
GB8906168D0 (en) 1989-03-17 1989-05-04 Pfizer Ltd Therapeutic agents
BR9713027A (pt) * 1996-11-12 2000-01-25 Novartis Ag Derivados de pirazol úteis como herbicidas
SE9702564D0 (sv) 1997-07-02 1997-07-02 Astra Ab New compounds

Similar Documents

Publication Publication Date Title
JP2002512243A5 (enExample)
JP2005508967A5 (enExample)
JP2007517044A5 (enExample)
JP2010535722A5 (enExample)
CA2514191A1 (en) Compound inhibiting dipeptidyl peptidase iv
WO2002040486A3 (en) METHODS OF TREATING p38 KINASE-ASSOCIATED CONDITIONS AND PYRROLOTRIAZINE COMPOUNDS USEFUL AS KINASE INHIBITORS
JP2012528166A5 (enExample)
JP2002502874A5 (enExample)
JP2004533444A5 (enExample)
JP2005535586A5 (enExample)
JP2001526269A5 (enExample)
JP2008525416A5 (enExample)
JP2013507425A5 (enExample)
JP2001525411A5 (enExample)
JP2009533410A5 (enExample)
NO20060220L (no) Forbindelser med inhiberene aktivitet mot natriumavhengige transportorer
JP2009536620A5 (enExample)
AR049239A1 (es) Compuestos heterociclicos inhibidores de la proteina kinasa (erk-2) y metodo de inhibicion
JP2007534636A5 (enExample)
JP2010530431A5 (enExample)
CY1108792T1 (el) Παραγωγα διοξανιου-2-αλκυλκαρβαμικου, η παρασκευη τους και η εφαρμογη τους στην θεραπευτικη αγωγη
JP2011505347A5 (enExample)
JP2010501478A5 (enExample)
JP2005502621A5 (enExample)
JP2005508962A5 (enExample)